NCT00041977View on ClinicalTrials.gov

Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2002

Conditions
Acne Rosacea
Interventions
DRUG

doxycycline hyclate 20 mg twice daily

Trial Locations (7)

17033

Milton S. Hershey Medical Center, Hershey

19104

University of Pennsylvania, Philadelphia

23507

David Pariser, MD, Norfolk

32610

University of Florida, Gainesville

33104

Beer and Houck/Florida Dermatology Institute, West Palm Beach

33136

University of Miami Medical Center, Miami

40202

University of Louisville, Louisville

Sponsors
All Listed Sponsors
lead

CollaGenex Pharmaceuticals

INDUSTRY

NCT00041977 - Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea | Biotech Hunter | Biotech Hunter